Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular dise...
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
About this item
Full title
Author / Creator
Publisher
United States: Mosby, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Mosby, Inc
Subjects
More information
Scope and Contents
Contents
Background The impact of nonpersistence on events and of events on persistence is unclear. We studied the effects of nonpersistence on outcomes and events on nonadherence in a randomized placebo controlled trial in 40 countries on 25,620 patients. Methods In the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTAR...
Alternative Titles
Full title
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1416045776
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1416045776
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2013.04.016
